{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:36:43Z","timestamp":1753893403522,"version":"3.41.2"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>Increased red blood cell count may result from primary erythrocytosis (polycythemia vera), but it is often due to secondary causes with increased erythropoietin levels. Secondary erythrocytosis may also be congenital due to different gene mutations of hemoglobin, hemoglobin stabilization proteins, EPO receptors, or oxygen sensing pathways. Von Hippel- Lindau gene mutation causes altered tissue oxygen sensation in VHL disease, usually with normal hemoglobin. Germline <jats:italic>VHL<\/jats:italic> mutations associate with classical VHL disease and represent genetic susceptibility for pheochromocytoma. <jats:italic>VHL<\/jats:italic> polymorphisms are mostly considered an innocent phenomenon. Still, some data indicate that these polymorphisms are not always harmless and can occur with prostate, renal, and colon cancer or even with isolated erythrocytosis. Seventy-eight patients referred to our department with elevated hemoglobin were screened for <jats:italic>VHL<\/jats:italic> mutations. There were no classical somatic <jats:italic>VHL<\/jats:italic> mutations. However, we found heterozygous (GA) or homozygous (AA) rs779805 <jats:italic>VHL<\/jats:italic> c.-195G&amp;gt;A polymorphism accompanied by erythrocytosis. These patients are <jats:italic>Jak-2<\/jats:italic> negative, with normal or elevated EPO levels, sometimes with family accumulations and often phlebotomy needs, and in some cases with malignancies in the family. No other cause of erythrocytosis was found. We use phlebotomy regularly, and for those with cardiovascular risk factors, we recommend aspirin.<\/jats:p>","DOI":"10.3389\/pore.2021.1609987","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T04:11:18Z","timestamp":1637899878000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["rs779805 Von Hippel-Lindau Gene Polymorphism Induced\/Related Polycythemia Entity, Clinical Features, Cancer Association, and Familiar Characteristics"],"prefix":"10.3389","volume":"27","author":[{"given":"Gyula","family":"Remenyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"Bereczky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9ka","family":"Gindele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniko","family":"Ujfalusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpad","family":"Illes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miklos","family":"Udvardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1751-553x.2008.01102.x","article-title":"The Classification and Diagnosis of Erythrocytosis","volume":"30","author":"McMullin","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/leu.2009.54","article-title":"The Complete Evaluation of Erythrocytosis: Congenital and Acquired","author":"Patnaik","year":"2009","journal-title":"Leukemia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0140-6736(93)91317-f","article-title":"Primary Familial and Congenital Polycythaemia","volume":"342","author":"Sokol","year":"1993","journal-title":"The Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/0140-6736(91)91705-y","article-title":"Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus","volume":"337","author":"Neumann","year":"1991","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/bjh.12431","article-title":"Novel Compound VHL Heterozygosity (VHLT124A\/L188V) Associated with Congenital Polycythaemia","volume":"162","author":"Lorenzo","year":"2013","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/pbc.25407","article-title":"Novel mutations in the von Hippel-Lindau gene associated with congenital polycythemia","volume":"62","author":"Sidhu","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/pbc.25056","article-title":"The Homozygous VHL D126N Missense Mutation Is Associated with Dramatically Elevated Erythropoietin Levels, Consequent Polycythemia, and Early Onset Severe Pulmonary Hypertension","volume":"61","author":"Sarangi","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1182\/blood-2012-11-469296","article-title":"Novel Homozygous VHL Mutation in Exon 2 Is Associated with Congenital Polycythemia but Not with Cancer","volume":"121","author":"Lanikova","year":"2013","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and Diagnosis of Myeloproliferative Neoplasms: the 2008 World Health Organization Criteria and point-of-care Diagnostic Algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1186\/1756-0500-7-638","article-title":"Two single nucleotide polymorphisms in the von Hippel-Lindau tumor suppressor gene in Taiwanese with renal cell carcinoma","volume":"7","author":"Wang","year":"2014","journal-title":"BMC Res Notes"},{"key":"B12","first-page":"13","article-title":"Colorectal Cancer Risk in Relation to Hypoxia Inducible Factor-1\u03b1 (Hif-1 \u03b1) and Von Hippel-Lindau (Vhl) Gene Polymorphisms","volume-title":"Int J Hematol Oncol","author":"Demirel","year":""},{"key":"B13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1089\/dna.2011.1408","article-title":"Association between VHL Single Nucleotide Polymorphism (Rs779805) and the Susceptibility to Prostate Cancer in Chinese","volume":"31","author":"Chen","year":"2012","journal-title":"DNA Cel Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1182\/HEMATOLOGY.2019000047","article-title":"Diagnostic Workflow for Hereditary Erythrocytosis and Thrombocytosis","volume":"2019","author":"Mf","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1006\/bcmd.2002.0488","article-title":"Endemic Polycythemia in Russia: Mutation in the VHL Gene","volume":"28","author":"Ang","year":"2002","journal-title":"Blood Cell Mol Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3324\/haematol.2012.070508","article-title":"The Phenotype of Polycythemia Due to Croatian Homozygous VHL (571C>G:H191D) Mutation Is Different from that of Chuvash Polycythemia","volume":"98","author":"Tomasic","year":"2013","journal-title":"Haematologica"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1182\/blood-2003-07-2550","article-title":"The Worldwide Distribution of the VHL 598C>T Mutation Indicates a Single Founding Event","volume":"103","author":"Liu","year":"2004","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1158\/0008-5472.CAN-14-1161","volume":"74","author":"Couv\u00e9","year":"2014","journal-title":"Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesisCancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56980-0","article-title":"Germline Polymorphisms in the Von Hippel-Lindau and Hypoxia-Inducible Factor 1-alpha Genes, Gene-Environment and Gene-Gene Interactions and Renal Cell Cancer","volume":"10","author":"van de Pol","year":"2020","journal-title":"Sci Rep"},{"key":"B20","first-page":"5781","article-title":"Renal Cell Carcinoma Risk Is Associated with the Interactions of APOE, VHL and MTHFR Gene Polymorphisms","volume":"8","author":"Lv","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028829","article-title":"Functional Promoter -31G>C Variant in Survivin Gene Is Associated with Risk and Progression of Renal Cell Cancer in a Chinese Population","volume":"7","author":"Qin","year":"2012","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1002312","DOI":"10.1371\/journal.pgen.1002312","article-title":"Von Hippel-Lindau (VHL) Inactivation in Sporadic clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors","volume":"7","author":"Moore","year":"2011","journal-title":"PLoS Gene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/bjh.15647","article-title":"A Guideline for the Management of Specific Situations in Polycythaemia Vera and Secondary Erythrocytosis","volume":"184","author":"McMullin","year":"2019","journal-title":"Br J Haematol"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2021.1609987\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T04:11:22Z","timestamp":1637899882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2021.1609987\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":23,"alternative-id":["10.3389\/pore.2021.1609987"],"URL":"https:\/\/doi.org\/10.3389\/pore.2021.1609987","relation":{},"ISSN":["1532-2807"],"issn-type":[{"type":"electronic","value":"1532-2807"}],"subject":[],"published":{"date-parts":[[2021,11,26]]},"article-number":"1609987"}}